We use cookies to improve your experience on our website. Read about how we use cookies and how you can control them by reviewing the Cookie section of our Privacy Policy. By continuing to use this website, you consent to our use of these cookies.
B-cell maturation antigen (BCMA) is a transmembrane protein member of the tumor necrosis factor (TNF) receptor superfamily, predominantly expressed on plasma cells, including malignant myeloma cells.1-3 Preclinical studies have shown that BCMA is essential for the survival of these cell types.1,3 Therefore, BCMA is a promising target protein in multiple myeloma through investigational therapies such as chimeric antigen receptor (CAR) T cell therapy, bispecific T-cell engagers, and antibody drug conjugates, among others.1,2
Use the form below to create one account that will be used across both BMS Science and Bolder Science. Clinical trials that you save on either site will be shown together on your dashboard on Bolder Science. If you already have an account, you can log in here.